Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153644 · ClinicalTrials.gov registry record
Helping People With Health Conditions Make Birth Control Decisions
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 67
- Enrollment target
NCT03153644: Completed study, sponsored by University of Michigan.
NCT03153644 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03153644 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The purpose of this project is to describe how contraceptive services are currently being delivered to women with medical conditions who seek care in community-based primary care settings, such as family medicine and internal medicine clinical offices.
Primary Outcome
A semi-structured interview will be used to identify patient-, provider- and practice-level factors that are relevant to the design and implementation of a contraceptive decision aid.
Interventions
- BEHAVIORAL Interview
- BEHAVIORAL Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2020-06-30 |
What the finished NCT03153644 record still lists
NCT03153644 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Interview is the first listed.
NCT03153644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03153644 about?
NCT03153644 is a clinical study titled "Helping People With Health Conditions Make Birth Control Decisions". The purpose of this project is to describe how contraceptive services are currently being delivered to women with medical conditions who seek care in community-based primary care settings, such as family medicine and internal medicine clinical offices.
What is the current status of trial NCT03153644?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2017-09-07. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03153644?
The interventions under investigation include: Interview (BEHAVIORAL), Observation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03153644?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI